- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
IOM Gives Marijuana Study High Priority
9 January 1997 7:45 pm
WASHINGTON--At President Clinton's request, the Institute of Medicine (IOM) has agreed to undertake a thorough review of claims that smoking marijuana can have medical benefits. Plans for the new study, expected to cost roughly $1 million and take 18 months to complete, were approved earlier this week by a governing board of the National Academy of Sciences, the IOM's parent body.
Studies in the 1970s and 1980s found that an active ingredient in marijuana smoke--tetrahydrocannabinol (THC)--has some value in reducing nausea and vomiting caused by chemotherapy. Based on these findings, the Food and Drug Administration since 1985 has permitted doctors to prescribe THC pills. But claims that smoking marijuana works better than taking pills have not been validated by clinical research.
The long-standing controversy over the medical use of marijuana erupted again this winter, triggered by a campaign in California to relax restrictions on its use as a therapeutic drug. The IOM study will examine all the published research on this topic and evaluate the benefits claimed for marijuana compared to those offered by other medicines. The IOM has not named the members of its panel.